Human tumor cells induce angiogenesis through positive feedback between CD147 and insulin-like growth factor-I

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Chen, Yanke ^a,b   Gou, Xingchun ^c   Ke, Xia ^b   Cui, Hongyong ^b   Chen, Zhinan ^b  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^c XI'AN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD147 ANTIGEN; SMALL INTERFERING RNA; SOMATOMEDIN C; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CELL LINE; CELL MIGRATION; CELL PROLIFERATION; CELL STRUCTURE; COCULTURE; CONTROLLED STUDY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; POSITIVE FEEDBACK; PROTEIN EXPRESSION; PROTEIN SECRETION; TUBE FORMATION; TUMOR VASCULARIZATION; UPREGULATION;

ANTIGENS, CD147; CELL LINE, TUMOR; COCULTURE TECHNIQUES; FEEDBACK, PHYSIOLOGICAL; GENE KNOCKDOWN TECHNIQUES; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INSULIN-LIKE GROWTH FACTOR I; NEOVASCULARIZATION, PATHOLOGIC;

EID: 84864250238     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0040965     Document Type: Article

References (42)

1. Folkman J, (1995) Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1: 27-31.
2. Hanahan D, Weinberg RA, (2000) The hallmarks of cancer. Cell 100: 57-70.
3. Hanahan D, Folkman J, (1996) Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86: 353-364.
4. Folkman J, (1997) Angiogenesis and angiogenesis inhibition: an overview. EXS 79: 1-8.
5. Naumov GN, Akslen LA, Folkman J, (2006) Role of angiogenesis in human tumor dormancy: animal models of the angiogenic switch. Cell Cycle 5: 1779-1787.
6. Zigrino P, Loffek S, Mauch C, (2005) Tumor-stroma interactions: their role in the control of tumor cell invasion. Biochimie 87: 321-328.
7. Koh W, Stratman AN, Sacharidou A, Davis GE, (2008) In vitro three dimensional collagen matrix models of endothelial lumen formation during vasculogenesis and angiogenesis. Methods Enzymol 443: 83-101.
8. Riethdorf S, Reimers N, Assmann V, Kornfeld JW, Terracciano L, et al. (2006) High incidence of EMMPRIN expression in human tumors. Int J Cancer 119: 1800-1810.
9. Zheng HC, Takahashi H, Murai Y, Cui ZG, Nomoto K, et al. (2006) Upregulated EMMPRIN/CD147 might contribute to growth and angiogenesis of gastric carcinoma: a good marker for local invasion and prognosis. Br J Cancer 95: 1371-1378.
10. Yang X, Dai J, Li T, Zhang P, Ma Q, et al. (2010) Expression of EMMPRIN in adenoid cystic carcinoma of salivary glands: correlation with tumor progression and patients' prognosis. Oral Oncol 46: 755-760.
11. Voigt H, Vetter-Kauczok CS, Schrama D, Hofmann UB, Becker JC, et al. (2009) CD147 impacts angiogenesis and metastasis formation. Cancer Invest 27: 329-333.
12. Xu J, Xu HY, Zhang Q, Song F, Jiang JL, et al. (2007) HAb18G/CD147 functions in invasion and metastasis of hepatocellular carcinoma. Mol Cancer Res 5: 605-614.
13. Li R, Huang L, Guo H, Toole BP, (2001) Basigin (murine EMMPRIN) stimulates matrix metalloproteinase production by fibroblasts. J Cell Physiol 186: 371-379.
14. Sun J, Hemler ME, (2001) Regulation of MMP-1 and MMP-2 production through CD147/extracellular matrix metalloproteinase inducer interactions. Cancer Res 61: 2276-2281.
15. Caudroy S, Polette M, Nawrocki-Raby B, Cao J, Toole BP, et al. (2002) EMMPRIN-mediated MMP regulation in tumor and endothelial cells. Clin Exp Metastasis 19: 697-702.
16. Tang Y, Nakada MT, Rafferty P, Laraio J, McCabe FL, et al. (2006) Regulation of vascular endothelial growth factor expression by EMMPRIN via the PI3K-Akt signaling pathway. Mol Cancer Res 4: 371-377.
17. Dai L, Bratoeva M, Toole BP, Qin Z, Parsons C, (2011) KSHV activation of VEGF secretion and invasion for endothelial cells is mediated through viral upregulation of emmprin-induced signal transduction. Int J Cancer.
18. Bougatef F, Quemener C, Kellouche S, Naimi B, Podgorniak MP, et al. (2009) EMMPRIN promotes angiogenesis through hypoxia-inducible factor-2alpha-mediated regulation of soluble VEGF isoforms and their receptor VEGFR-2. Blood 114: 5547-5556.
19. Wellmann S, Taube T, Paal K, Graf VEH, Geilen W, et al. (2001) Specific reverse transcription-PCR quantification of vascular endothelial growth factor (VEGF) splice variants by LightCycler technology. Clin Chem 47: 654-660.
20. Zhu W, Khachi S, Hao Q, Shen F, Young WL, et al. (2008) Upregulation of EMMPRIN after permanent focal cerebral ischemia. Neurochem Int 52: 1086-1091.
21. Han M, Trotta P, Coleman C, Linask KK, (2006) MCT-4, A511/Basigin and EF5 expression patterns during early chick cardiomyogenesis indicate cardiac cell differentiation occurs in a hypoxic environment. Dev Dyn 235: 124-131.
22. Menashi S, Serova M, Ma L, Vignot S, Mourah S, et al. (2003) Regulation of extracellular matrix metalloproteinase inducer and matrix metalloproteinase expression by amphiregulin in transformed human breast epithelial cells. Cancer Res 63: 7575-7580.
23. Pushkarsky T, Yurchenko V, Vanpouille C, Brichacek B, Vaisman I, et al. (2005) Cell surface expression of CD147/EMMPRIN is regulated by cyclophilin 60. J Biol Chem 280: 27866-27871.
24. Yurchenko V, Pushkarsky T, Li JH, Dai WW, Sherry B, et al. (2005) Regulation of CD147 cell surface expression: involvement of the proline residue in the CD147 transmembrane domain. J Biol Chem 280: 17013-17019.
25. Wu J, Ru NY, Zhang Y, Li Y, Wei D, et al. (2011) HAb18G/CD147 promotes epithelial-mesenchymal transition through TGF-beta signaling and is transcriptionally regulated by Slug. Oncogene 30: 4410-4427.
26. Le Floch R, Chiche J, Marchiq I, Naiken T, Ilk K, et al. (2011) CD147 subunit of lactate/H+ symporters MCT1 and hypoxia-inducible MCT4 is critical for energetics and growth of glycolytic tumors. Proc Natl Acad Sci U S A 108: 16663-16668.
27. Chen Y, Zhang H, Gou X, Horikawa Y, Xing J, et al. (2009) Upregulation of HAb18G/CD147 in activated human umbilical vein endothelial cells enhances the angiogenesis. Cancer Lett 278: 113-121.
28. Bordenave L, Baquey C, Bareille R, Lefebvre F, Lauroua C, et al. (1993) Endothelial cell compatibility testing of three different Pellethanes. J Biomed Mater Res 27: 1367-1381.
29. Kim JB, (2005) Three-dimensional tissue culture models in cancer biology. Semin Cancer Biol 15: 365-377.
30. Liotta LA, Kohn EC, (2001) The microenvironment of the tumour-host interface. Nature 411: 375-379.
31. Millimaggi D, Mari M, D'Ascenzo S, Carosa E, Jannini EA, et al. (2007) Tumor vesicle-associated CD147 modulates the angiogenic capability of endothelial cells. Neoplasia 9: 349-357.
32. Tang Y, Kesavan P, Nakada MT, Yan L, (2004) Tumor-stroma interaction: positive feedback regulation of extracellular matrix metalloproteinase inducer (EMMPRIN) expression and matrix metalloproteinase-dependent generation of soluble EMMPRIN. Mol Cancer Res 2: 73-80.
33. Horiuchi A, Imai T, Shimizu M, Oka K, Wang C, et al. (2002) Hypoxia-induced changes in the expression of VEGF, HIF-1 alpha and cell cycle-related molecules in ovarian cancer cells. Anticancer Res 22: 2697-2702.
34. Semenza GL, (2001) Regulation of hypoxia-induced angiogenesis: a chaperone escorts VEGF to the dance. J Clin Invest 108: 39-40.
35. Turner KJ, Crew JP, Wykoff CC, Watson PH, Poulsom R, et al. (2002) The hypoxia-inducible genes VEGF and CA9 are differentially regulated in superficial vs invasive bladder cancer. Br J Cancer 86: 1276-1282.
36. Shi YH, Bingle L, Gong LH, Wang YX, Corke KP, et al. (2007) Basic FGF augments hypoxia induced HIF-1-alpha expression and VEGF release in T47D breast cancer cells. Pathology 39: 396-400.
37. Joung YH, Lee MY, Lim EJ, Kim MS, Hwang TS, et al. (2007) Hypoxia activates the IGF-1 expression through STAT5b in human HepG2 cells. Biochem Biophys Res Commun 358: 733-738.
38. Baumgartner I, Isner JM, (1998) Stimulation of peripheral angiogenesis by vascular endothelial growth factor (VEGF). Vasa 27: 201-206.
39. Clark DE, Charnock-Jones DS, (1998) Placental angiogenesis: the role of the VEGF family of proteins. Angiogenesis 2: 309-318.
40. Qin Z, Dai L, Slomiany MG, Toole BP, Parsons C, (2010) Direct activation of emmprin and associated pathogenesis by an oncogenic herpesvirus. Cancer Res 70: 3884-3889.
41. Shigematsu S, Yamauchi K, Nakajima K, Iijima S, Aizawa T, et al. (1999) IGF-1 regulates migration and angiogenesis of human endothelial cells. Endocr J 46.
42. Holly J, (2004) IGF-1, IGFBP-3, and cancer risk. Lancet 364: 325-326; author reply 326-327.